Dave Pantoja, PhD
@oncoscientist
Followers
562
Following
8K
Media
142
Statuses
3K
Associate Professor/PI @wakeforestmed @WakeCancer interested metabolism, immunotherapy, cardio-oncology, health & educational disparities. Opinions my own.
NC via Arecibo, PR 🇵🇷
Joined February 2014
Thank you @ACS_Research for your support to find new alternatives for treatment of breast cancer and cancer therapy related cardiotoxicities.
Congrats @oncoscientist for your new @ACS_Research Scholar Grant on #breastcancer #CardioOncology. I wish all grants were awarded in large novelty checks! @wakeforestmed @WakeCancer
2
3
23
Exciting day of stimulating talks at the 2025 Cancer Research Center Symposium @FralinBiomed @virginia_tech @WakeCancer
0
2
6
Outstanding work @KLCookLab.
Recent interview regarding our Cell Reports Medicine manuscript @wakeforestmed @WakeCancer
0
0
2
Grateful for the invitation to present our work @APSPhysiology on strategies to prevent cancer therapy-related cardiotoxicities supported by @ACSNews @WakeCancer #APS2025
0
2
14
RT @KFW_Lab: 📢 New KFW Lab paper out now in @ScienceAdvances! 📢.We show that AML cells resist chemotherapy by reversing the ATP synthase re….
0
29
0
Congrats @KLCookLab !.
Honored to be recognized tomorrow as @WFCTSI @wakeforestmed 2024 Research Award in Mid-Career Basic/Translational category. Congrats to all the winners this year @JaredWeis @KadakiaKunal @birkensarah @SalemGIOncDoc @asouth_neph @HKlepinMD
0
0
3
RT @oncodaily: A day to spread awareness about cancer - @KridelSteven . #Cancer #OncoDaily #MedEd #MedX #MedNews #….
0
3
0
Happy to share my recent @AACR TME interest group interview #Microbiome #BreastCancer @WakeCancer @wakeforestmed
0
2
8
RT @EmboMolMed: Do not miss the review by K. Cook and colleagues @KLCookLab @wakeforestmed that discusses the role of #GutMicrobiota in #Br….
0
2
0
RT @KLCookLab: First publication of 2025! @alana_arnone @HeekeMd @KatherineAnsley @MarissaHMcNatt @WakeCancer @LevineCancer @wakeforestmed….
0
2
0
I guess this post got lost in all the holiday cheer. but I am stoked to be part of this work uncovering how endocrine therapies influence the breast microbiome and breast cancer risk. Congrats to @klcook lab and the rest of the team!.
Closing out 2024 with a publication!@wakeforestmed @WakeCancer @alana_arnone @oncoscientist @chibaAkiko @A_THOMASMD @MarissaHMcNatt .Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer risk.
0
0
5
RT @KLCookLab: Closing out 2024 with a publication!@wakeforestmed @WakeCancer @alana_arnone @oncoscientist @chibaAkiko @A_THOMASMD @Marissa….
0
3
0
RT @amsocmatbio: Sign up and join our first e-symposia of 2025, on such an important topic on #WomensHealth #ECMatrix! 👇🏻 #ScienceNoBoundar….
0
6
0
RT @KLCookLab: It’s definitely a group effort! #DreamTeam @KatherineAnsley @haleywmabry @EmilyDouglasMD @WakeCancer @wakeforestmed Thanks f….
0
1
0
RT @KLCookLab: @WakeRedox annual retreat has a great line-up of speakers showing breathe and depth of redox biology research @wakeforestmed….
0
3
0
Very proud of our students!!!.
Congratulations to Terry @WakeMCB in @oncoscientist lab for 🥈and Kenysha @WakeIPP in my lab for 🥉place awards for graduate student presentations at @WakeSurgEd Surgical Science Research Day. Mohamed in my lab also won 🥉in the fellow category! @wakeforestmed
0
0
8
One of the best parts of @tmcs_2024 is that one of the organizers @costas_koumenis will serenade at dinner!
0
4
10
Excited to kickoff our immuno-oncology retreat with dinner with our keynote speaker Brent Hanks @DukeMedSchool and our @WakeCancer @LevineCancer team @mpdrc
0
0
8
Congrats ! @KLCookLab and team @WakeCancer.
Hot off the press! New collaborative study @UBuffalo @wakeforestmed @HMBalcom linking gut microbiome with gut leakiness and visceral adipose tissue in postmenopausal women in @MicrobiomeJ .
0
0
3
Congrats @KLCookLab. Happy to be part of the team!.
We made it to the cover of the September issue @CAPR_AACR! First author @alana_arnone @WakeCancer @WakeIPP @wakeforestmed showed impact of diet on #BreastCancer risk using preclinical models.
0
0
7